Immunotherapy for Head and Neck Cancer Treatment
1 Visualizzazioni
• 07/02/23
0
0
Incorporare
administrator
Iscritti
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti